Industry / Germany
Research Sector Still Facing Challenges
November 2007 | Industry NewsIn 2006, 29 new molecular entities were launched in Germany, according to the German Association of Research-based Pharmaceutical Companies, VFA. This is lightly higher than the average over the past 19 years, and
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
